Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06195852 · ClinicalTrials.gov registry record · NA
Maximizing the Reach of Universal Child Sexual Abuse Prevention: An Equivalence Trial
A NA study, sponsored by New York University.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT06195852: Clinical Trial NA study, sponsored by New York University.
NCT06195852 is a NA study that was terminated before completion, run by New York University. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06195852, a NA study, was terminated before completion, sponsored by New York University.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test the equivalence of two delivery modalities of a universal child sexual abuse prevention program, Safe Touches: usual vs. modified. The aims are to: 1. Determine the equivalence of effectiveness between usual and modified Safe Touches 2. Assess the maintenance of gains between usual and modified Safe Touches 3. Examine factors that may impact the future dissemination and implementation
Primary Outcome
6-items rated on 3- point scale (Yes, Unsure, No) where higher scores indicate a greater knowledge of safe and unsafe touches
Interventions
- BEHAVIORAL Usual Safe Touches
- BEHAVIORAL Modified Safe Touches
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2025-04-21 |
| Phase | NA |
Why NCT06195852 stopped before completion
NCT06195852 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Safe Touches is the first listed.
NCT06195852 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06195852 about?
NCT06195852 is a clinical study titled "Maximizing the Reach of Universal Child Sexual Abuse Prevention: An Equivalence Trial". The goal of this clinical trial is to test the equivalence of two delivery modalities of a universal child sexual abuse prevention program, Safe Touches: usual vs. modified. The aims are to: 1. Determine the equivalence of effectiveness between usual and modified Safe Touches 2. Assess the maintena...
What is the current status of trial NCT06195852?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2024-09-01. Estimated completion is 2025-04-21.
What interventions are being tested in trial NCT06195852?
The interventions under investigation include: Usual Safe Touches (BEHAVIORAL), Modified Safe Touches (BEHAVIORAL).
Who is sponsoring clinical trial NCT06195852?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06195852's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI